National Health Investors, Inc.
NHINYSEReal Estate● Active
$69.53
$-0.90(-1.28%)
Market Cap$3.4B
P/E Ratio—
52W High$91.38
52W Low$68.8
National Health Investors, Inc. (NHI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NHI · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 4, 2026EPS Actual
$1.24
Est. $1.21 · +2.5%
Revenue
$0.07B
Est. $0.07B · +4.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 4, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 6-Quarter EPS Beat Streak
NHI reports quarterly as a NYSE-listed REIT - Healthcare Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.87 | — | — | — | $0.07B | — |
| ▲ Q2 FY2026 | May 4, 2026 | $1.21 | $1.24 | +2.5% | $0.07B | $0.07B | +4.2% |
| ▲ Q1 FY2026 | Feb 26, 2026 | $0.80 | $1.22 | +52.3% | $0.07B | $0.07B | +1.8% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $1.24 | $1.32 | +6.5% | $0.09B | $0.10B | -5.5% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $1.16 | $1.22 | +5.2% | $0.09B | $0.09B | +6.7% |
| ▲ Q2 FY2025 | May 5, 2025 | $1.13 | $1.15 | +1.8% | $0.09B | $0.09B | +3.6% |
| ▲ Q1 FY2025 | Feb 25, 2025 | $1.10 | $1.13 | +2.7% | $0.09B | $0.08B | +5.7% |
| ▼ Q4 FY2024 | Nov 5, 2024 | $1.07 | $1.03 | -3.7% | $0.08B | $0.08B | -1.0% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.87
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 4, 2026Beat
EPS Actual
$1.24
EPS Est.
$1.21
EPS Surpr.
+2.5%
Revenue
$0.07B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$1.22
EPS Est.
$0.80
EPS Surpr.
+52.3%
Revenue
$0.07B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$1.32
EPS Est.
$1.24
EPS Surpr.
+6.5%
Revenue
$0.09B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$1.22
EPS Est.
$1.16
EPS Surpr.
+5.2%
Revenue
$0.09B
Q2 FY2025
May 5, 2025Beat
EPS Actual
$1.15
EPS Est.
$1.13
EPS Surpr.
+1.8%
Revenue
$0.09B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$1.13
EPS Est.
$1.10
EPS Surpr.
+2.7%
Revenue
$0.09B
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
$1.03
EPS Est.
$1.07
EPS Surpr.
-3.7%
Revenue
$0.08B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.88 | $0.88 | $0.89 | 1 |
| Q3 FY2027 | $0.87 | $0.87 | $0.88 | 1 |
| Q2 FY2027 | $0.85 | $0.86 | $0.87 | 1 |
| Q1 FY2027 | $0.84 | $0.85 | $0.86 | 1 |
| Q4 FY2026 | $0.82 | $0.83 | $0.83 | 1 |
| Q3 FY2026 | $1.18 | $1.19 | $1.20 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 4, 2026 | +2.5% | $76.71 | $75.71 | -1.30% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +52.3% | $88.13 | $87.68 | -0.51% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +6.5% | $76.17 | $75.31 | -1.13% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +5.2% | $73.29 | $72.72 | -0.78% |
| ▲ Q2 FY2025 | May 5, 2025 | +1.8% | $75.87 | $76.04 | +0.22% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +2.7% | $70.70 | $71.29 | +0.83% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -3.7% | $75.92 | $76.73 | +1.07% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +7.3% | $72.48 | $74.33 | +2.55% |
Q2 FY2026-1.30%
Report Date
May 4, 2026
EPS Beat/Miss
+2.5%
Price Before
$76.71
Price After
$75.71
Q1 FY2026-0.51%
Report Date
Feb 26, 2026
EPS Beat/Miss
+52.3%
Price Before
$88.13
Price After
$87.68
Q4 FY2025-1.13%
Report Date
Nov 6, 2025
EPS Beat/Miss
+6.5%
Price Before
$76.17
Price After
$75.31
Q3 FY2025-0.78%
Report Date
Aug 6, 2025
EPS Beat/Miss
+5.2%
Price Before
$73.29
Price After
$72.72
Q2 FY2025+0.22%
Report Date
May 5, 2025
EPS Beat/Miss
+1.8%
Price Before
$75.87
Price After
$76.04
Q1 FY2025+0.83%
Report Date
Feb 25, 2025
EPS Beat/Miss
+2.7%
Price Before
$70.70
Price After
$71.29
Q4 FY2024+1.07%
Report Date
Nov 5, 2024
EPS Beat/Miss
-3.7%
Price Before
$75.92
Price After
$76.73
Q3 FY2024+2.55%
Report Date
Aug 6, 2024
EPS Beat/Miss
+7.3%
Price Before
$72.48
Price After
$74.33
Avg Beat Reaction-0.02%
Avg Miss Reaction+1.07%
Beat Rate7 / 8 quarters
Largest Move+2.55% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NHI ends December
National Health Investors, Inc. (NHI) most recently reported earnings on May 4, 2026 for Q2 FY2026, posting EPS of $1.24 — beating the analyst consensus of $1.21 by +2.5%. NHI has beaten EPS estimates for 6 consecutive quarters. The next NHI earnings date is expected around September 1, 2026.
Each quarter, investors track NHI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NHI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NHI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NHI earnings · 5 questionsNational Health Investors, Inc.'s next earnings report is expected around September 1, 2026. NHI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NHI historically reports after market close (AMC).
NHI earnings datewhen is NHI earningsNHI next earnings datewhen does NHI report earningsNHI earnings calendar
▸ Source: FMP · National Health Investors, Inc. SEC filings · US GAAP · National Health Investors, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026